effects of xuebijing injection combined with ulinastatin on endotoxin and inflammatory factors in treatment of severe acute pancreatitis

Clicks: 297
ID: 183275
2016
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Objective: To investigate the effects of Xuebijing injection combined with ulinastatin on endotoxin and inflammatory factors in treatment of severe acute pancreatitis. Methods: A total of 52 patients with severe acute pancreatitis in our hospital from July 2014 to July 2015 were selected and divided into two groups: Group A (n=26) and Group B (n=26). All of the patients received conventional treatment and necessary nutrition support. Patients of Group A were treated with ulinastatin on the basis of conventional treatment and nutrition support. Patients of Group B were treated with Xuebijing injection on the basis of Group A. Before and after treatment, the levels of serum endotoxin, hs-CRP, IL-6, IL-8, IL-10 and TNF-毩 were detected. Results: After treatment, the levels of hs-CRP and endotoxin in two groups were lower than before treatment, and the Group B decreased more significantly than the Group A. The levels of IL-6, IL-8 and TNF-毩 in two groups were lower than before treatment, and the Group B decreased more than the Group A, while levels of IL-10 increased more than before treatment, and the Group B increased more than the Group A. Conclusion: Xuebijing injection combined with ulinastatin can significantly improve the clinical treatment effect through reducing serum endotoxin levels and inhibiting the release of inflammatory factors of patients with severe acute pancreatitis.
Reference Key
xiao2016journaleffects Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Hua-Xin Xiao;Ke-Jiang Tang
Journal journal of communications
Year 2016
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.